Literature DB >> 3157594

Insulin recovery in pancreas and host organs of islet grafts.

B Ziegler, H J Hahn, M Ziegler.   

Abstract

The method of insulin determination is a useful tool for detecting surviving beta cells in the pancreas of diabetic animals and in organs used as sites of islet graft. Therefore, we have studied the insulin recovery in tissue homogenates. The data show that a high recovery rate of insulin (more than 95%) was reached, when the phosphoric acid-alcoholic tissue extract was stored at -20 degrees C and diluted with RIA buffer immediately before radioimmunoassay. When acid-ethanol supernatants were neutralized the recovery rate was diminished to 73.4 +/- 4.0% in pancreas and to 61.0 +/- 6.2% in liver homogenates, respectively. Glucagon was degraded when diluted extracts were stored at -20 degrees C for different periods of time. The diabetogenic action of streptozotocin (STZ) could be demonstrated for doses ranging between 30 and 55 mg/kg body weight. STZ caused a dose-dependent decrease of pancreatic insulin whereas the glucagon content was significantly enhanced in diabetic animals. The glucagon content was not normalized when normoglycemia was achieved by syngeneic islet transplantation. Insulin extracted from spleen used as a site for transplantation of 900 neonatal rat islets showed a high biological variation ranging from 0.7 to 6.4 nmol insulin per spleen, 10-100% of the content of the equivalent number of freshly isolated islets these animals received.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3157594     DOI: 10.1055/s-0029-1210419

Source DB:  PubMed          Journal:  Exp Clin Endocrinol        ISSN: 0232-7384


  7 in total

1.  Monoclonal antibody-mediated cytotoxicity against rat beta cells detected in vitro does not cause beta-cell destruction in vivo.

Authors:  B Ziegler; S Lucke; E Köhler; B Hehmke; M Schlosser; S Witt; W Besch; M Ziegler
Journal:  Diabetologia       Date:  1992-07       Impact factor: 10.122

2.  Reversibility of the acute toxic effect of cyclosporin A on pancreatic B cells of Wistar rats.

Authors:  H J Hahn; A Dunger; F Laube; W Besch; E Radloff; C Kauert; G Kotzke
Journal:  Diabetologia       Date:  1986-08       Impact factor: 10.122

3.  Prevention and suppression of autoimmune pancreatic beta-cell destruction in BB rats by syngeneic lymphocytes obtained from long-term normoglycaemic donors.

Authors:  B Kuttler; A Dunger; H D Volk; T Diamantstein; H J Hahn
Journal:  Diabetologia       Date:  1991-02       Impact factor: 10.122

4.  Prolongation of rat pancreatic islet allograft survival by treatment of recipient rats with monoclonal anti-interleukin-2 receptor antibody and cyclosporin.

Authors:  H J Hahn; B Kuttler; A Dunger; I Klöting; S Lucke; H D Volk; R von Baehr; T Diamantstein
Journal:  Diabetologia       Date:  1987-01       Impact factor: 10.122

5.  Development of cytotoxic islet cell antibodies in rats following damage of the pancreas by complete Freund's adjuvant combined with a nondiabetogenic dose of streptozotocin.

Authors:  K D Kohnert; B Ziegler; B Hehmke; K Fält; R Odselius; M Ziegler
Journal:  Int J Pancreatol       Date:  1990-01

6.  Human islet purification: a prospective comparison of Euro-Ficoll and bovine serum albumin density gradients.

Authors:  D R Chadwick; G S Robertson; H Contractor; S Swift; S Rose; S T Thirdborough; R Chamberlain; R F James; P R Bell; N J London
Journal:  Acta Diabetol       Date:  1993       Impact factor: 4.280

7.  Augmentation of streptozotocin-induced hyperglycemia in mice by prior treatment with complete Freund's adjuvant.

Authors:  K D Kohnert; B Ziegler; K Fält; M Ziegler
Journal:  Int J Pancreatol       Date:  1989-04
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.